Page last updated: 2024-08-22

angiotensin ii and torcetrapib

angiotensin ii has been researched along with torcetrapib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adam, LP; Chang, M; Chen, AYA; Chen, XQ; Finlay, HJ; Harikrishnan, LS; Huang, CS; Jiang, J; Kamau, MG; Lawrence, RM; Levesque, P; Li, J; Qiao, JX; Rampulla, R; Salvati, ME; Sleph, PG; Taylor, DS; Wang, TC; Wexler, RR; Xu, C; Yin, X	1
Bénardeau, A; Capponi, AM; Clerc, RG; Funder, JW; Garriz, JM; Hainaut, E; Hoflack, JC; Niesor, EJ; Perez, A; Pflieger, P; Stauffer, A; Weibel, F	1

Other Studies

2 other study(ies) available for angiotensin ii and torcetrapib

Article	Year
Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) Inhibitor. ACS medicinal chemistry letters, 2019, Jun-13, Volume: 10, Issue:6 Topics:	2019
Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels. Journal of hypertension, 2010, Volume: 28, Issue:8 Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Aldosterone; Amides; Angiotensin II; Animals; Anticholesteremic Agents; Blood Pressure; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Cytosol; Enzyme Induction; Esters; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Gene Expression Profiling; Humans; Hypertension; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Quinolines; Rats; Rats, Inbred SHR; RNA, Small Interfering; Sodium Channels; Structure-Activity Relationship; Sulfhydryl Compounds	2010

Article

Year

Discovery of a Lead Triphenylethanamine Cholesterol Ester Transfer Protein (CETP) Inhibitor.

ACS medicinal chemistry letters, 2019, Jun-13, Volume: 10, Issue:6

Topics:

2019

Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels.

Journal of hypertension, 2010, Volume: 28, Issue:8

Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Aldosterone; Amides; Angiotensin II; Animals; Anticholesteremic Agents; Blood Pressure; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP11B2; Cytosol; Enzyme Induction; Esters; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Gene Expression Profiling; Humans; Hypertension; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Quinolines; Rats; Rats, Inbred SHR; RNA, Small Interfering; Sodium Channels; Structure-Activity Relationship; Sulfhydryl Compounds

2010